Related references
Note: Only part of the references are listed.Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Metabolomic profiling for second primary lung cancer: A pilot case-control study
Jacqueline Aredo et al.
LUNG CANCER (2021)
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma
Man Hsin Hung et al.
NATURE COMMUNICATIONS (2021)
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
Elio Adib et al.
CLINICAL CANCER RESEARCH (2021)
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine
Yasaman Barekatain et al.
NATURE COMMUNICATIONS (2021)
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Guangchun Han et al.
NATURE COMMUNICATIONS (2021)
Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA
Carolin Dorothea Strobl et al.
MOLECULAR CANCER THERAPEUTICS (2020)
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
Amin H. Nassar et al.
BRITISH JOURNAL OF CANCER (2020)
PRMT5 Is Required for T Cell Survival and Proliferation by Maintaining Cytokine Signaling
Yukinori Tanaka et al.
FRONTIERS IN IMMUNOLOGY (2020)
PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity
Hyungsoo Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Protein Arginine Methyltransferase 5 in T Lymphocyte Biology
Shouvonik Sengupta et al.
TRENDS IN IMMUNOLOGY (2020)
The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
Benedikt Jacobs et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Leptin induced in vitro development of ovarian follicles in sheep is related to the expression of P450 aromatase and steroidogenesis
P. Anil Kumar et al.
THERIOGENOLOGY (2019)
PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia
Aliaksandra Radzisheuskaya et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
Balazs Acs et al.
NATURE COMMUNICATIONS (2019)
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
Claudia Sorrentino et al.
FRONTIERS IN IMMUNOLOGY (2019)
PRMT5 in gene regulation and hematologic malignancies
Fen Zhu et al.
GENES & DISEASES (2019)
Targeting the insulin-like growth factor-1 receptor in MTAP-deficient renal cell carcinoma
Jihao Xu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
Zahid Q. Bonday et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma
Haiwei Du et al.
FRONTIERS IN PHARMACOLOGY (2018)
Arginine methylation controls the strength of gamma c-family cytokine signaling in T cell maintenance
Maia Inoue et al.
NATURE IMMUNOLOGY (2018)
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer
Harshita Shailesh et al.
Oncotarget (2018)
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
Jiqiu Cheng et al.
NATURE COMMUNICATIONS (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
MTA-mediated inhibition of human T cells: Mechanism and MTAP overexpression as putative overcoming strategy
Carolin D. Strobl et al.
CANCER RESEARCH (2017)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma
Wesley J. Woollard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination
Jiwon Lee et al.
NATURE MEDICINE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
Konstantinos J. Mavrakis et al.
SCIENCE (2016)
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
Gregory V. Kryukov et al.
SCIENCE (2016)
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon et al.
CELL REPORTS (2016)
Suppressive effects of tumor cell-derived 5 '-deoxy-5 '-methylthioadenosine on human T cells
Frederik C. Henrich et al.
ONCOIMMUNOLOGY (2016)
f Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M. Sholl et al.
JCI INSIGHT (2016)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Immunomodulatory Metabolites Released by the Frog-Killing Fungus Batrachochytrium dendrobatidis
Louise A. Rollins-Smith et al.
INFECTION AND IMMUNITY (2015)
Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma
Hong-Lin He et al.
MEDICINE (2015)
MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients
C. -Y. Su et al.
EJSO (2014)
The metabolite 5′-methylthioadenosine signals through the adenosine receptor A2B in melanoma
Katharina Limm et al.
EUROPEAN JOURNAL OF CANCER (2014)
Methylthioadenosine Reprograms Macrophage Activation through Adenosine Receptor Stimulation
Peter A. Keyel et al.
PLOS ONE (2014)
Lupus autoimmunity altered by cellular methylation metabolism
Mei-Ling Yang et al.
AUTOIMMUNITY (2013)
Methylation in the p53 promoter in epithelial ovarian cancer
Marcela Chmelarova et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Distinct metabolic differences between various human cancer and primary cells
Katja Dettmer et al.
ELECTROPHORESIS (2013)
Primate Genome Gain and Loss: A Bone Dysplasia, Muscular Dystrophy, and Bone Cancer Syndrome Resulting from Mutated Retroviral-Derived MTAP Transcripts
Olga Camacho-Vanegas et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Down-Regulation of Methylthioadenosine Phosphorylase (MTAP) Induces Progression of Hepatocellular Carcinoma via Accumulation of 5′-Deoxy-5′-Methylthioadenosine (MTA)
Georgi Kirovski et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Downregulation of Methylthioadenosin Phosphorylase by Homozygous Deletion in Gastric Carcinoma
Jin Kim et al.
GENES CHROMOSOMES & CANCER (2011)
The mechanisms by which polyamines accelerate tumor spread
Kuniyasu Soda
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency
Wee-Wei Tee et al.
GENES & DEVELOPMENT (2010)
Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis
B. Moreno et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Mice Heterozygous for Germ-line Mutations in Methylthioadenosine Phosphorylase (MTAP) Die Prematurely of T-Cell Lymphoma
Yuwaraj Kadariya et al.
CANCER RESEARCH (2009)
Protein Arginine Methylation in Mammals: Who, What, and Why
Mark T. Bedford et al.
MOLECULAR CELL (2009)
Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases
Elfatih Elzein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data
Christine Vogel et al.
NATURE PROTOCOLS (2008)
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino3-(4-fluorophenyl) pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition
Takuma Mihara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Synthesis of 5′-methylthio coformycins:: Specific inhibitors for malarial adenosine deaminase
Peter C. Tyler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation
Peng Lu et al.
NATURE BIOTECHNOLOGY (2007)
Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury
Chun-Xiao Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y)
Y Kadariya et al.
BIOCHEMICAL JOURNAL (2005)
Novel amino acid derived natural products from the ascidian Atriolum robustum:: Identification and pharmacological characterization of a unique adenosine derivative
S Kehraus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Picomolar transition state analogue inhibitors of human 5′-methylthioadeno sine phosphorylase and X-ray structure with MT-immucillin-A
V Singh et al.
BIOCHEMISTRY (2004)
Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs
DE Lukashev et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation
IP Pogribny et al.
CANCER LETTERS (2002)
The role and regulation of adenosine in the central nervous system
TV Dunwiddie et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Share Paper
